Edition:
United States

Syndax Pharmaceuticals Inc (SNDX.OQ)

SNDX.OQ on NASDAQ Stock Exchange Global Select Market

5.06USD
4:00pm EDT
Change (% chg)

$-0.05 (-0.98%)
Prev Close
$5.11
Open
$5.14
Day's High
$5.14
Day's Low
$5.00
Volume
47,086
Avg. Vol
66,516
52-wk High
$15.20
52-wk Low
$3.39

Chart for

About

Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough Therapy designation by the FDA following positive results from its Phase IIb... (more)

Overall

Beta: --
Market Cap(Mil.): $270.64
Shares Outstanding(Mil.): 22.22
Dividend: --
Yield (%): --

Financials

  SNDX.OQ Industry Sector
P/E (TTM): -- 29.30 32.54
EPS (TTM): -2.99 -- --
ROI: -42.86 14.23 13.82
ROE: -48.61 15.46 15.25

Earnings vs. Estimates